Cogent Biosciences, Inc.

COGT · Healthcare · Cogent Biosciences, Inc., a clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases

Cogent Biosciences, Inc. (COGT), in the Healthcare sector, has 7 disclosed filings on Paydirt over the trailing twelve months from 6 corporate insiders: 0 purchases and 7 sales. Filers took a median of 4 days from execution to disclosure, and the most recent trade was executed Aug 27 and filed Aug 31. The most active filer was Fairmount Funds Management LLC with 3 filings.

Add to watchlist

Filings, ttm

0 buys · 7 sells

Traders, ttm

6 insiders

Volume, ttmiDollar value disclosed in the window

$383.9M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Aug 27

Filed Aug 31

ADViAverage daily dollar volume

$84.0M

market data

Share price · 12M

$34.76 (+177.9%)

Adjusted for splits and dividends.

Volume by month

Buys $25.3M Sells $383.9M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

FL Fairmount Funds Management LLC Director 3 filings JG

John L. Green Chief Financial Officer 1 filing EK

Evan Kearns Chief Legal Officer 1 filing AM

Arlene Morris Director 1 filing CP

Cole Pinnow Chief Commercial Officer 1 filing JR

John Edward Robinson Chief Scientific Officer 1 filing JS

Jessica Sachs Chief Medical Officer 1 filing

Recent filings

Arlene MorrisSALE Director $1.7M
45,510 sh across 2 lots
Exec Aug 27
Filed Aug 31 · 5:01 PM ET Fairmount Funds Management LLCSALE Director $242.6M
7,000,000 sh × $34.66
Exec Mar 31
Filed Mar 31 · 5:30 PM ET Fairmount Funds Management LLCSALE Director $127.4M
3,500,000 sh × $36.40
Exec Jan 22
Filed Jan 22 · 5:30 PM ET John Edward RobinsonSALE Chief Scientific Officer $3.5M
90,000 sh × $38.74
Exec Dec 26 2025
Filed Dec 30 2025 · 5:30 PM ET Jessica SachsSALE Chief Medical Officer $3.2M
82,642 sh × $38.70
Exec Dec 26 2025
Filed Dec 30 2025 · 5:30 PM ET John L. GreenSALE Chief Financial Officer $3.0M
77,000 sh × $38.68
Exec Dec 26 2025
Filed Dec 30 2025 · 5:30 PM ET Evan KearnsSALE Chief Legal Officer $2.5M
65,000 sh × $38.70
Exec Dec 26 2025
Filed Dec 30 2025 · 5:30 PM ET Fairmount Funds Management LLCPURCHASE Director $25.0M
2,777,777 sh × $9.00
Exec Jul 10 2025
Filed Jul 14 2025 · 5:30 PM ET Cole PinnowPURCHASE Chief Commercial Officer $332K
43,750 sh × $7.60
Exec Jan 14 2025
Filed Jan 15 2025 · 5:30 PM ET